David E I Pyott
Director, Alnylam Pharmaceuticals, Inc.
Bought, 12 months
$0.0M
Sold, 12 months
$1.1M
Companies
1
Latest trade
Jun 1, 2026
Companies
Alnylam Pharmaceuticals, Inc.Director −$1.1M
Trades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.